Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Use of Stabilizers in MDI Production

Posted on By

SOP for Use of Stabilizers in MDI Production

Stabilizer Handling Procedures in MDI Production

1) Purpose

The purpose of this SOP is to establish procedures for the use of stabilizers in metered-dose inhaler (MDI) production to ensure product stability, efficacy, and compliance with regulatory requirements.

2) Scope

This SOP applies to all personnel involved in the handling and use of stabilizers within the MDI production facility, including production operators, chemical engineers, and quality control technicians.

3) Responsibilities

The responsibilities for this SOP include handling stabilizers safely, monitoring their usage, conducting quality checks, and ensuring compliance with specifications. Specific roles include:
Production Operators: Handle and add stabilizers to MDI formulations according to approved procedures.
Chemical Engineers: Assess stabilizer compatibility and conduct quality assessments.
Quality Control Technicians: Verify stabilizer content and ensure adherence to specifications.

See also  SOP for Formulation Development for MDIs

4) Procedure

4.1 Stabilizer Handling
4.1.1 Store stabilizers in controlled conditions and protect them from contamination.
4.1.2 Use accurate weighing and measuring techniques during stabilizer addition.
4.2 Mixing and Blending
4.2.1 Incorporate stabilizers into MDI formulations under controlled mixing conditions.
4.2.2 Ensure uniform distribution of stabilizers throughout the formulation.
4.3 Quality Checks
4.3.1 Perform in-process checks

to verify stabilizer concentrations and ensure product consistency.
4.3.2 Conduct stability testing to assess the long-term effects of stabilizers on MDI formulations.
4.4 Documentation
4.4.1 Maintain records of stabilizer handling procedures, including batch records and quality control reports.
4.4.2 Document stability testing results, deviations observed, and any corrective actions taken.

See also  SOP for Use of Solvents in MDI Production

5) Abbreviations, if any

MDI: Metered-Dose Inhaler
SOP: Standard Operating Procedure

6) Documents, if any

Stabilizer handling protocols, stability testing reports, batch records, and quality control documents should be maintained.

7) Reference, if any

Refer to regulatory guidelines from agencies such as the FDA, EMA, and ICH for stabilizer use in pharmaceutical manufacturing and quality control.

8) SOP Version

Version 1.0

Metered-Dose Inhaler Tags:Analytical Method Development MDIs, Batch Manufacturing Record MDI, Calibration MDI Equipment, Cleaning Equipment MDIs, Color Consistency Testing MDI, Contamination Prevention MDI, Documentation MDI Manufacturing, Final Product Inspection MDI, Formulation Development MDI, In-process Testing Inhalers, Inhaler Manufacturing Procedures, Inhaler Quality Control SOP, Labeling MDI SOP, MDI Production SOPs, MDI Storage Conditions, Metered-Dose Inhaler SOP, Microbial Testing Inhalers, Packaging of MDIs Procedure, Particle Size Analysis MDIs, Preservative Efficacy MDIs, Process Optimization MDIs, Process Validation MDIs, Propellant Testing MDIs, Quality Testing MDIs, Raw Material Inspection MDIs, Solvents Use in MDI Production, Stability Testing MDIs, Sterility Maintenance MDI, Training Personnel MDI Production, Waste Disposal MDI Production

Post navigation

Previous Post: SOP for Eye Drop Filling Machine
Next Post: SOP for Pharmacovigilance System Validation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version